| Practical considerations in medical cannabis administration and dosing CA MacCallum, EB Russo European journal of internal medicine 49, 12-19, 2018 | 709 | 2018 |
| Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process A Bhaskar, A Bell, M Boivin, W Briques, M Brown, H Clarke, C Cyr, ... Journal of cannabis research 3, 1-12, 2021 | 117 | 2021 |
| “Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations CA MacCallum, LA Lo, M Boivin European Journal of Internal Medicine 89, 10-18, 2021 | 57 | 2021 |
| Therapeutic use of psilocybin: Practical considerations for dosing and administration CA MacCallum, LA Lo, CA Pistawka, JK Deol Frontiers in Psychiatry 13, 1040217, 2022 | 34 | 2022 |
| Practical strategies using medical cannabis to reduce harms associated with long term opioid use in chronic pain CA MacCallum, L Eadie, AM Barr, M Boivin, S Lu Frontiers in pharmacology 12, 633168, 2021 | 34 | 2021 |
| Duration of neurocognitive impairment with medical cannabis use: a scoping review L Eadie, LA Lo, A Christiansen, JR Brubacher, AM Barr, WJ Panenka, ... Frontiers in psychiatry 12, 638962, 2021 | 27 | 2021 |
| Clinical practice guidelines for cannabis and cannabinoid-based medicines in the management of chronic pain and co-occurring conditions AD Bell, C MacCallum, S Margolese, Z Walsh, P Wright, PJ Daeninck, ... Cannabis and Cannabinoid Research 9 (2), 669-687, 2024 | 16 | 2024 |
| Cannabidiol‐associated hepatotoxicity: A systematic review and meta‐analysis LA Lo, A Christiansen, L Eadie, JC Strickland, DD Kim, M Boivin, AM Barr, ... Journal of Internal Medicine 293 (6), 724-752, 2023 | 16 | 2023 |
| Characterization of mental health in cannabis dispensary users, using structured clinical interviews and standardized assessment instruments JC Yau, SM Yu, WJ Panenka, H Pearce, KM Gicas, RM Procyshyn, ... BMC psychiatry 19, 1-12, 2019 | 16 | 2019 |
| Canadian clinical practice guidelines for the use of plant-based cannabis and cannabinoid-based products in the management of chronic non-cancer pain and co-occurring … P Wright, Z Walsh, S Margolese, T Sanchez, S Arlt, L Belle-Isle, MS Pierre, ... BMJ open 10 (5), e036114, 2020 | 15 | 2020 |
| A clinical framework for evaluating cannabis product quality and safety CA MacCallum, LA Lo, CA Pistawka, M Boivin Cannabis and Cannabinoid Research 8 (3), 567-574, 2023 | 11 | 2023 |
| A clinical framework for assessing cannabis-related impairment risk CA MacCallum, LA Lo, CA Pistawka, A Christiansen, M Boivin, ... Frontiers in psychiatry 13, 883517, 2022 | 8 | 2022 |
| Cannabidiol as a harm reduction strategy for people who use drugs: a rapid review LA Lo, CA MacCallum, K Nanson, M Koehn, I Mitchell, MJ Milloy, Z Walsh, ... The Canadian Journal of Psychiatry 68 (8), 557-571, 2023 | 6 | 2023 |
| Differences in those who prefer smoking cannabis to other consumption forms for mental health: what can be learned to promote safer methods of consumption? LA Lo, CA MacCallum, JC Yau, AM Barr Journal of addictive diseases 41 (3), 258-262, 2023 | 5 | 2023 |
| Cannabinoids and pain SN Narouze Springer, 2021 | 5 | 2021 |
| Cannabinoid-based medicines: dosing, titration & monitoring CA MacCallum, L de Freitas, LA Lo, M Boivin Cannabinoids and Pain, 167-178, 2021 | 4 | 2021 |
| Product Safety and Quality Control CA MacCallum, LA Lo, F Betts, M Koehn Cannabinoids and Pain, 249-258, 2021 | 4 | 2021 |
| Cannabinoid-Related Adverse Events and Impairment CA MacCallum, L de Freitas, LA Lo, L Eadie, JR Brubacher Cannabinoids and Pain, 293-306, 2021 | 4 | 2021 |
| Format CA MacCallum, EB Russo Eur J Intern Med 49, 12-19, 2018 | 4 | 2018 |
| Why a distinct medical stream is necessary to support patients using cannabis for medical purposes C Costiniuk, CA MacCallum, M Boivin, S Rueda, G Lacasse, Z Walsh, ... Journal of Cannabis Research 5 (1), 25, 2023 | 3 | 2023 |
